可解释的AI驱动精确临床试验丰富:通过II期抑郁症试验来展示NetraAI平台
Joseph Geraci1,2,3,4, Bessi Qorri5, Mike Tsay1
1NetraMark Corp., Toronto, ON, Canada.
NPJ digital medicine
|December 8, 2025
概括
NetraAI是一个可解释的人工智能平台,识别患者子组以改善临床试验结果. 这种方法提高了各种疾病个性化医学的预测准确性.
科学领域:
- 人工智能在医学中的应用
- 临床试验优化 临床试验优化
- 个性化医疗是个性化的医疗.
背景情况:
- 临床试验失败是常见的,原因是患者异质性和小样本大小,这减少了统计能力.
- 识别对治疗有反应的特定患者亚组对于提高试验成功率至关重要.
研究的目的:
- 介绍NetraAI,一个可解释的AI平台,旨在从高维临床数据中发现高效果大小的患者亚群.
- 评估NetraAI在治疗耐药抑郁症的第二阶段胺胺试验中预测治疗结果方面的表现.
主要方法:
- NetraAI集成了动态系统建模,进化远程内存特征选择和大语言模型 (LLM) 洞察力.
- 该平台分析了精神病学尺度数据和来自63名患者的MRI衍生的特征,这些患者参加了二期胺试验.
- 我们比较了NetraAI与传统机器学习 (ML) 模型的预测性能.
主要成果:
- 与标准的ML模型相比,NetraAI的预测准确度提高了25-30%.
- NetraAI确定了一个10个临床变量模型,该模型将预测AUC提高了0.32.
- 一个8MRI特征模型在检测响应者方面实现了95%的准确性和100%的特异性.
结论:
- 可解释的动态AI可以有效地从小,丰富的数据集中识别出具有临床意义的患者子组.
- 尼特拉AI的精密丰富策略显示了提高临床试验成功率的潜力.
- 该平台可以通过识别可能从各种医学领域的特定疗法中受益的患者来实现个性化医疗.
相关概念视频
01:11Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
01:16Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K